The remediation of infectious diseases is an ongoing concern in healthcare structures due to the continued loss of efficacies of existing schedules and, in particular, the poignant threat of multidrug resistance. In the search for new therapies plants have emerged as an attractive option owing to their vast chemical resources. Allied to this feature is the widespread use of plants in traditional approaches towards infectious diseases. As far as the family Amaryllidaceae is concerned, around fifty of its members are identifiable with such distinctive functions in traditional medicine. This review examines the in vitro antibacterial activities of its plant extracts and sheds light on instances where these are corroborative of the traditional usage.
(a) AminovR.I. (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in Microbiology, 1, article 134, 1–7; (b) Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery, 6, 29–40; (c) Silver LL. (2011) Challenges of antibacterial discovery. Clinical Microbiology Reviews, 24, 71–109.
2.
(a) WHO (2001) WHO Global Strategy for Containment of Antimicrobial Resistance.WHO Press, World Health Organization, Geneva, Switzerland; (b) WHO (2011) Core Components for Infection Prevention and Control Programmes. WHO Press, World Health Organization, Geneva, Switzerland; (c) WHO (2012) The Evolving Threat of Antimicrobial Resistance: Options for Action. WHO Press, World Health Organization, Geneva, Switzerland.
3.
(a) CowanM.M. (1999) Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12, 564–582; (b) Martin K, Ernst E. (2003) Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. Journal of Antimicrobial Chemotherapy, 51, 241–246; (c) Mahady GB. (2005) Medicinal plants for the prevention and treatment of bacterial infections. Current Pharmaceutical Design, 11, 2405–2427.
MeerowA.W., SnijmanD.A. (1998) Amaryllidaceae. In The Families and Genera of Vascular Plants, Vol. 3, KubitzkiK. (Ed). Springer, Berlin, Germany, 83–110.
6.
(a) WattJ.M., Breyer-BrandwijkM.G. (1962) The Medicinal and Poisonous Plants of Southern and Eastern Africa.Livingston Ltd., Edinburgh; (b) Hutchings A, Scott AH, Lewis G, Cunningham AB. (1996) Zulu Medicinal Plants: an Inventory. University of Natal Press, Pietermaritzburg; (c) Viladomat F, Bastida J, Codina C, Nair JJ, Campbell WE. (1997) Alkaloids of the South African Amaryllidaceae. In Recent Research Developments in Phytochemistry, Vol. 1, Pandali SG. (Ed). Research Signpost Publishers, Trivandrum, India, 131–171; (d) Fennell CW, Van Staden J. (2001) Crinum species in traditional and modern medicine. Journal of Ethnopharmacology, 78, 15–26; (e) Bastida J, Lavilla R, Viladomat F. (2006) Chemical and biological aspects of Narcissus alkaloids. In The Alkaloids. Cordell GA. (Ed). Elsevier, Amsterdam, Netherlands, 87–179; (f) Kornienko A, Evidente A. (2008) Chemistry, biology and medicinal potential of narciclasine and its congeners. Chemical Reviews, 108, 1982–2014; (g) Nair JJ, Bastida J, Codina C, Viladomat F, Van Staden J. (2013) Alkaloids of the South African Amaryllidaceae: a review. Natural Product Communications, 8, 1335–1550; (h) Nair JJ, Van Staden J, Bonnet SL, Wilhelm A. (2017) Distribution and diversity of usage of the Amaryllidaceae in the traditional remediation of infectious diseases. Natural Product Communications, 12, 635–639; (i) Nair JJ, Van Staden J. (2013) Pharmacological and toxicological insights to the South African Amaryllidaceae. Food and Chemical Toxicology, 62, 262–275; (j) Nair JJ, Van Staden J. (2014) Traditional usage, phytochemistry and pharmacology of the South African medicinal plant Boophone disticha (L.f.) Herb. (Amaryllidaceae). Journal of Ethnopharmacology, 151, 12–26; (k) Louw CAM, Regnier TJC, Korsten L. (2002) Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. Journal of Ethnopharmacology, 82, 147–154.
7.
(a) HeinrichM. (2010) Galanthamine from Galanthus and other Amaryllidaceae- chemistry and biology based on traditional use. In The Alkaloids.CordellG.A. (Ed). Academic Press, Chennai, 157–165; (b) Nair JJ, Van Staden J, Bastida J. (2016) Cytotoxic alkaloid constituents of the Amaryllidaceae. In Studies in Natural Products Chemistry, Vol. 49, Rahman AU. (Ed). Elsevier, Amsterdam, 107–156.
CeriottiG. (1967) Narciclasine: an antimitotic substance from Narcisssus bulbs. Nature, 213, 595–596.
10.
IevenM., Van den BergheD.A., MertensF., VlietinckA., LammensE. (1979) Screening of higher plants for biological activities. I. Antimicrobial activity. Planta Medica, 36, 311–321.
11.
(a) RabeT., Van StadenJ. (1997) Antibacterial activity of South African plants used for medicinal purposes. Journal of Ethnopharmacology, 56, 81–87; (b) Shale TL, Stirk WA, Van Staden J. (1999) Screening of medicinal plants used in Lesotho for antibacterial and anti-inflammatory activity. Journal of Ethnopharmacology, 67, 347–354; (c) Heyman HM, Hussein AA, Meyer JJM, Lall N. (2009) Antibacterial activity of South African medicinal plants against methicillin resistant Staphylococcus aureus. Pharmaceutical Biology, 47, 67–71; (d) Cheesman L, Nair JJ, Van Staden J. (2012) Antibacterial activity of crinane alkaloids from Boophone disticha (Amaryllidaceae). Journal of Ethnopharmacology, 140, 405–408.
12.
(a) MadikizelaB., NdhlalaA.R., FinnieJ.F., Van StadenJ. (2012) Ethnopharmacological study of plants from Pondoland used against diarrhoea. Journal of Ethnopharmacology, 141, 61–71; (b) Madikizela B, Ndhlala AR, Finnie JF, Van Staden J. (2013) In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms. Evidence-Based Complementary and Alternative Medicine, 840719; (c) Madikizela B, Ndhlala AR, Finnie JF, Van Staden J. (2014) Antimycobacterial, anti-inflammatory and genotoxicity evaluation of plants used for the treatment of tuberculosis and related symptoms in South Africa. Journal of Ethnopharmacology, 153, 386–391.
13.
NyilaM.A., LeonardC.M., HusseinA.A., LallN. (2012) Activity of South African medicinal plants against Listeria monocytogenes biofilms, and isolation of active compounds from Acacia karroo. South African Journal of Botany, 78, 220–227.
14.
(a) GrosvenorP.W., SuprionoA., GrayD.O. (1995) Medicinal plants from Riau province, Sumatra, Indonesia. Part 2: Antibacterial and antifungal activity. Journal of Ethnopharmacology, 45, 97–111; (b) Kelmanson JE, Jäger AK, Van Staden J. (2000) Zulu medicinal plants with antibacterial activity. Journal of Ethnopharmacology, 69, 241–246; (c) Ali H, König GM, Khalid SA, Wright AD, Kaminsky R. (2002) Evaluation of selected Sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity. Journal of Ethnopharmacology, 83, 219–228; (d) Nkanwen ERS, Gatsing D, Ngamga D, Fodouop SPC, Tane P. (2009) Antibacterial agents from the leaves of Crinum purpurascens Herb. (Amaryllidaceae). African Health Sciences, 9, 264–269; (e) Gatsing D, Tchakoute V, Ngamga D, Kuiate J-R, Tamokou J-D-D, Nji-Nkah BF, Tchouanguep FM, Fodouop SPC. (2009) In vitro antibacterial activity of Crinum purpurascens Herb. leaf extract against the Salmonella species causing Typhoid fever and its toxicological evaluation. Iranian Journal of Medical Sciences, 34, 126–136; (f) Ilavenil SB, Kaleeswaran B, Ravikumar S. (2010) Evaluation of antibacterial activity and phytochemical analysis of Crinum asiaticum. International Journal of Current Research, 1, 35–40; (g) Refaat J, Kamel MS, Ramadan MA, Ali AA. (2011) Analgesic, anti-inflammatory and antimicrobial activities of Crinum augustum Rox. and Crinum asiaticum L. Research Journal of Pharmacognosy and Phytochemistry, 3, 289–296; (h) Iannello C, Bastida J, Bonvicini F, Antognoni F, Gentilomi GA, Poli F. (2014) Chemical composition, and in vitro antibacterial and antifungal activity of an alkaloid extract from Crinum angustum Steud. Natural Product Research, 28, 704–710; (i) Udegbunam SO, Udegbunam RI, Nnaji TO, Anyanwu MU, Kene ROC, Anika SM. (2015) Antimicrobial and antioxidant effect of methanolic Crinum jagus bulb extract in wound healing. Journal of Intercultural Ethnopharmacology, 4, 239–248.
15.
(a) ElgorashiE.E., Van StadenJ. (2004) Pharmacological screening of six Amaryllidaceae species. Journal of Ethnopharmacology, 90, 27–32; (b) Buwa LV, Van Staden J. (2006) Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. Journal of Ethnopharmacology, 103, 139–142; (c) Ndhlala AR, Finnie JF, Van Staden J. (2011) Plant composition, pharmacological properties and mutagenic evaluation of a commercial Zulu herbal mixture: Imbiza ephuzwato. Journal of Ethnopharmacology, 133, 663–674; (d) Ncube B, Nair JJ, Rárová L, Strnad M, Finnie JF, Van Staden J. (2015) Seasonal pharmacological properties and alkaloid content in Cyrtanthus contractus N.E. Br. South African Journal of Botany, 97, 69–76; (e) Bhat RB, Jacobs TV. (1995) Traditional herbal medicine in Transkei. Journal of Ethnopharmacology, 48, 7–12.
16.
(a) ŞenerB., BingölF., ErdoğanI., BowersW.S., EvansP.H. (1998) Biological activities of some Turkish medicinal plants. Pure and Applied Chemistry, 70, 403–406; (b) Ločárek M, Nováková J, Klouček P, Hošt'álková A, Kokoška L, Gábrlová L, Šafratová M, Opletal L, Cahlíková L. (2015) Antifungal and antibacterial activity of extracts and alkaloids of selected Amaryllidaceae species. Natural Product Communications, 10, 1537–1540; (c) Bussmann RW, Malca-García G, Glenn A, Sharon D, Chait G, Díaz D, Pourmand K, Jonat B, Somogy S, Guardado G, Aguirre C, Chan R, Meyer K, Kuhlman A, Townesmith A, Effio-Carbajal J, Frías-Fernandez F, Benito M. (2010) Minimum inhibitory concentrations of medicinal plants used in Northern Peru as antibacterial remedies. Journal of Ethnopharmacology, 132, 101–108; (d) Bussmann RW, Glenn A. (2011) Medicinal plants used in Northern Peru for the treatment of bacterial and fungal infections and inflammation symptoms. Journal of Medicinal Plants Research, 5, 1297–1304; (e) Rosli N, Sumathy V, Vikneswaran M, Sreeramanan S. (2014) Growth profile and SEM analyses of Candida albicans and Escherichia coli with Hymenocallis littoralis (Jacq.) Salisb leaf extract. Tropical Biomedicine, 31, 871–879; (f) Li A, Zhu Y, He X, Tian X, Xu L, Ni W, Jiang P. (2008) Evaluation of antimicrobial activity of certain Chinese plants used in folkloric medicine. World Journal of Microbiology and Biotechnology, 24, 569–572; (g) Lee DG, Lee AY, Kim S-J, Jung Y-S, Lee D-H, Cho EJ, Lee S. (2014) Antibacterial phytosterols and alkaloids from Lycoris radiata. Natural Product Sciences, 20, 107–112.
17.
(a) Sür-AltinerD., GürkanE., MutluG., TuzlaciE., AngÖ. (1999) The antifungal activity of Pancratium maritimum. Fitoterapia, 70, 187–189; (b) Hetta MH, Shafei AA. (2013) Comparative cytotoxic and antimicrobial activities of the alkaloid content of Egyptian Pancratium maritimum L. fruits and flowers. Journal of American Science, 9, 104–109; (c) Pagning ALN, Tamokou J-D-D, Khan ML, Ali MI, Hameed A, Ngnokam D, Tapondjou LA, Kuiate J-R, Ali MS. (2016) Antimicrobial, antioxidant and butyrylcholinesterase inhibition activities of extracts and isolated compounds from Scadoxus pseudocaulus and semi-synthetic farrerol derivatives. South African Journal of Botany, 102, 166–174; (d) York T, De Wet H, Van Vuuren SF. (2011) Plants used for treating respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa. Journal of Ethnopharmacology, 135, 696–710; (e) York T, Van Vuuren SF, De Wet H. (2012) An antimicrobial evaluation of plants used for the treatment of respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa. Journal of Ethnopharmacology, 144, 118–127.
18.
(a) UnverN., Irem KayaG., Tansel OzturkH. (2005) Antimicrobial activity of Sternbergia sicula and Sternbergia lutea. Fitoterapia, 76, 226–229; (b) Martínez GJ, Barboza GE. (2010) Natural pharmacopoeia used in traditional Toba medicine for the treatment of parasitosis and skin disorders (Central Chaco, Argentina). Journal of Ethnopharmacology, 132, 86–100; (c) Sindiri MK, Machavarapu M, Vangalapati M. (2013) Antibacterial activity of methanolic extracts of Zephyranthes candida. Asian Journal of Pharmaceutical and Clinical Research, 6, 112–113.
19.
(a) ZhengY., JiangX., GaoF., SongJ., SunJ., WangL., SunX., LuZ., ZhangH. (2014) Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome. BMC Complementary & Alternative Medicine, 14, (400), 1–7; (b) Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PGA. (2015) Current perspectives in drug discovery against tuberculosis from natural products. International Journal of Mycobacteriology, 4, 165–183; (c) WHO (2015) Global Tuberculosis Report. WHO Press, World Health Organization, Geneva, Switzerland; (d) McGaw LJ, Lall N, Meyer JJM, Eloff JN. (2008) The potential of South African plants against Mycobacterium infections. Journal of Ethnopharmacology, 119, 482–500; (e) Anochie PI, Onyejepu N, Ogu AC, Adetunji MA, Efere LO, Onyeozirila AC, Onyeneke EC, Onyeneke CN, Obinna JU, Srikanth A, Bueno J. (2011) Anti-tuberculosis activities of medicinal plants used in the treatment of tuberculosis in HIV patients in Nigeria. African Journal of Microbiology Research, 5, 1126–1130; (f) Akintola AO, Kehinde AO, Adebiyi OE, Ademowo OG. (2013) Anti-tuberculosis activities of the crude methanolic extract and purified fractions of the bulb of Crinum jagus. Nigerian Journal of Physiological Sciences, 28, 135–140; (g) Tyagi JS, Sharma D. (2002) Mycobacterium smegmatis and tuberculosis. Trends in Microbiology, 10, 68–69; (h) Phelan J, Maitra A, McNerney R, Nair M, Gupta A, Coll F, Pain A, Bhakta S, Clark TG. (2015) The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. International Journal of Mycobacteriology, 4, 207–216; (i) Dey I, Keller K, Belley A, Chadee K. (2003) Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proceedings of the National Academy of Sciences, 100, 13561–13566; (j) Bansal K, Kapoor N, Narayana Y, Puzo G, Gilleron M, Balaji KN. (2009) PIM2 induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling. PloS One, 4, e4911.
20.
(a) RodriguesL.C., LockwoodD.N. (2011) Leprosy now: epidemiology, progress, challenges, and research gaps. The Lancet Infectious Diseases, 11, 464–470; (b) Nwude N, Ebong OO. (1980) Some plants used in the treatment of leprosy in Africa. Leprosy Review, 51, 11–18; (c) Johnsy G, Kaviyarasan V. (2015) Ethnomedicinal plants used for the treatment of leprosy in tribal peoples of Kanyakumari district. Global Journal of Pharmacology, 9, 190–195.
